Cyclo-oxygenase-2 mediated prostaglandin release regulates blood flow in connective tissue during mechanical loading in humans

Journal of Physiology

Volumn 551, Issue 2, 2003, Pages 683-689

  Langberg, H ^a   Boushel, R ^b   Skovgaard, D ^a   Risum, N ^a   Kjaer M ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Gina Cody School of Engineering and Computer Science   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2; INDOMETACIN; ISOENZYME; PROSTAGLANDIN; PROSTAGLANDIN E2; XENON 133;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CONNECTIVE TISSUE; CONTROLLED STUDY; ENZYME INHIBITION; EXERCISE; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; MICRODIALYSIS; MUSCLE CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; TISSUE BLOOD FLOW; TISSUE PERFUSION; INTERSTITIUM; MECHANICAL LOADING; REST;

ACHILLES TENDON; ADULT; CALIBRATION; CONNECTIVE TISSUE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EXERCISE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LEG; MEMBRANE PROTEINS; MICRODIALYSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; REGIONAL BLOOD FLOW; REST; XENON;

EID: 0141857812     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2003.046094     Document Type: Article

References (45)

1. Abrahamsson SO, Lundborg G & Lohmander LS (1989). Segmental variation in microstructure, matrix synthesis and cell proliferation in rabbit flexor tendon. Scand J Plast Reconstr Surg Hand Surg 23, 191-198.
2. Alfredson H, Forsgren S, Thorsen K & Lorentzon R (2001). In vivo microdialysis and immunohistochemical analyses of tendon tissue demonstrated high amounts of free glutamate and glutamate NMDAR1 receptors, but no signs of inflammation, in Jumper's knee. J Orthop Res 19, 881-886.
3. Alfredson H, Thorsen K & Lorentzon R (1999). In situ microdialysis in tendon tissue: high levels of glutamate, but not prostaglandin E2 in chronic Achilles tendon pain. Knee Surg Sports Traumatol Arthrosc 7, 378-381.
4. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC & Gregory SA (1996). Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97, 2672-2679.
5. Astrom M & Rausing A (1995). Chronic Achilles tendinopathy. A survey of surgical and histopathologic findings. Clin Orthop 316, 151-164.
6. Astrom M & Westlin N (1994). Blood flow in chronic Achilles tendinopathy. Clin Orthop 308, 166-172.
7. Ballou LR, Botting RM, Goorha S, Zhang J & Vane JR (2000). Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci U S A 97, 10272-10276.
8. Boushel R, Langberg H, Green S, Skovgaard D, Bulow J & Kjaer M (2000). Blood flow and oxygenation in peritendinous tissue and calf muscle during dynamic exercise in humans. J Physiol 524, 305-313.
9. Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ & Fitzgerald GA (1999). Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 289, 735-741.
10. Dahners LE, Gilbert JA, Lester GE, Taft TN & Payne LZ (1988). The effect of a nonsteroidal antiinflammatory drug on the healing of ligaments. Am J Sports Med 16, 641-646.
11. Davy KP, Herbert WG & Williams JH (1993). Effect of indomethacin on the pressor responses to sustained isometric contraction in humans. J Appl Physiol 75, 273-278.
12. Duffy SJ, Tran BT, New G, Tudball RN, Esler MD, Harper RW & Meredith IT (1998). Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. Am J Physiol 74, H1174-1183.
13. Elder CL, Dalners LE & Weinhold PS (2001). A cyclooxygenase-2 inhibitor impairs ligament healing in the rat. Am J Sports Med 29, 801-805.
14. Engelke KA, Halliwill JR, Proctor DN, Dietz NM & Joyner MJ (1996). Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. J Appl Physiol 81, 1807-1814.
15. Fredberg U (1997). Local corticosteroid injection in sports: review of literature and guidelines for treatment. Scand J Med Sci Sport 7, 131-139.
16. Gierse JK, Koboldt CM, Walker MC, Seibert K & Isakson PC (1999). Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 339, 607-614.
17. Kety SS (1951). The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 3, 1-41.
18. Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC & Stallings WC (1996). Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384, 644-648.
19. Langberg H, Bjorn C, Boushel R, Hellsten Y & Kjaer M (2002). Exercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J Physiol 542, 977-983.
20. Langberg H, Bulow J & Kjaer M (1998). Blood flow in the peritendinous space of the human Achilles tendon during exercise. Acta Physiol Scand 163, 149-153.
21. Langberg H, Bulow J & Kjaer M (1999a). Standardized intermittent static exercise increases peritendinous blood flow in human leg. Clin Physiol 19, 89-93.
22. Langberg H, Skovgaard D, Bulow J & Kjaer M (1999b). Negative interstitial pressure in the peritendinous region during exercise. J Appl Physiol 87, 999-1002.
23. Langberg H, Skovgaard D, Karamouzis M, Bulow J & Kjaer M (1999c). Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J Physiol 515, 919-927.
24. Langberg H, Skovgaard D, Petersen LJ Bulow J & Kjaer M (1999d). Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans. J Physiol 521, 299-306.
25. Lassen NA, Lindbjerg J & Munck O (1964). Measurement of blood-flow through skeletal muscle by intramuscular injection of Xenon-133. Lancet i (2), 686-689.
26. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA & Fitzgerald GA (1999). Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A 96, 272-277.
27. McLennan IS & Macdonald RE (1991). Prostaglandin synthetase and prostacyclin synthetase in mature rat skeletal muscles: immunohistochemical localisation to arterioles, tendons and connective tissues. J Anat 178, 243-253.
28. Mun-Bryce S & Rosenberg GA (1998). Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 274, R1203-1211.
29. Muscara MN, Vergnolle N, Lovren F, Triggle CR, Elliott SN, Asfaha S & Wallace JL (2000). Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br J Pharmacol 129, 1423-1430.
30. O'Banion MK (1999). Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 13, 45-82.
31. Ohberg L & Alfredson H (2002). Ultrasound guided sclerosis of neovessels in painful chronic Achilles tendinosis: pilot study of a new treatment. Br J Sports Med 36, 173-175.
32. Ostrom RS, Gregorian C, Drenan RM, Gabot K, Rana BK & Insel PA (2001). Key role for constitutive cyclooxygenase-2 of MDCK cells in basal signaling and response to released ATP. Am J Physiol Cell Physiol 281, C524-531.
33. Ouellet M, Riendeau D & Percival MD (2001). A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. Proc Natl Acad Sci U S A 98, 14583-14588.
34. Pohl U, De Wit C & Gloe T (2000). Large arterioles in the control of blood flow: role of endothelium-dependent dilation. Acta Physiol Scand 168, 505-510.
35. Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory SA & Isakson PC (1996). Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 184, 883-891.
36. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV & Woolf CJ (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410, 471-475.
37. Scheller D & Kolb J (1991). The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples. J Neurosci Methods 40, 31-38.
38. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L & Isakson P (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 91, 12013-12017.
39. Shoemaker JK, Naylor HL, Pozeg ZI & Hughson RL (1996). Failure of prostaglandins to modulate the time course of blood flow during dynamic forearm exercise in humans. J Appl Physiol 81, 1516-1521.
40. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K & Isakson PC (1998). Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A 95, 13313-13318.
41. Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L, Bynum D, Yang X & Banes AJ (2003). Il-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, Il-1 beta and Il-6 in human tendon cells. J Orthop Res 21, 256-264.
42. Vane JR, Bakhle YS & Botting RM (1998). Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38, 97-120.
43. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J & Willoughby DA (1994). Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 91, 2046-2050.
44. Wilson JR & Kapoor SC (1993). Contribution of prostaglandins to exercise-induced vasodilation in humans. Am J Physiol 265, H171-175.
45. Zhang Y, Shaffer A, Portanova J, Seibert K & Isakson PC (1997). Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J Pharmacol Exp Ther 283, 1069-1075.